Alnylam finds belly fat gene and drug target in UK Biobank study
pharmaphorum
JULY 28, 2022
. “We are currently testing this hypothesis, with the goal of pursuing a development candidate targeting INHBE in the near future,” said Paul Nioi, head of Alnylam’s human genetics group. The post Alnylam finds belly fat gene and drug target in UK Biobank study appeared first on.
52 
Let's personalize your content